Core Viewpoint - Axon Enterprise is facing investor concerns regarding its high valuation as it prepares to release its Q4 2025 earnings on February 24, amidst a broader market apprehension about high-growth tech firms trading at premium multiples [1] Company Overview - Axon Enterprise, headquartered in Scottsdale, Arizona, specializes in technology and weapons for law enforcement, military, and civilian use, including body-worn cameras, in-car cameras, TASER devices, and cloud software for evidence management [4] - The company operates in two segments: TASER and Software and Sensors, with the majority of revenue derived from the Software and Sensors segment, focusing on hardware and cloud-based systems for digital evidence [4] Recent Developments - Axon is expanding its AI capabilities, exemplified by its agreement to acquire Carbyne for $625 million, which aims to integrate cloud-native 911 technology into its ecosystem to enhance emergency response [2] - As AI integration progresses, there are questions about whether the upcoming Q4 results will validate the company's high valuation or serve as a reality check [3] Stock Performance - In 2026, AXON stock has declined 14% year-to-date, underperforming the S&P 500's 1.3% gain, following significant drops of nearly 10% and 7% on January 28 and 29, respectively [5] - The stock fell 4% in 2025, marking its first losing year since 2015 and snapping a nine-year streak of positive annual returns, while also underperforming the S&P 500's approximately 16% advance that year [5] Valuation Metrics - Axon is trading at a trailing price-to-earnings (P/E) ratio of 395, a forward P/E of 430, and a PEG ratio of 17.3, with a forward price-to-sales (P/S) ratio of 16.3, indicating significantly higher valuations compared to industry averages in aerospace and defense [6]